DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
Running, not enrolling · Phase 2
Conditions studied: Breast Cancer
In brief
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)
Key facts
- Study ID
- NCT04567420
- Run by
- Criterium, Inc.
- People needed
- 70
- Starts
- 2021-02-09
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-07-08
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Arizona Cancer Center — Tucson, Arizona, United States
- USC/Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Cedars-Sinai Medical Center — Los Angeles, California, United States
- University of Colorado Cancer Center — Aurora, Colorado, United States
- Intermountain — Golden, Colorado, United States
- Yale Cancer Center — New Haven, Connecticut, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Louisiana State University Health Sciences Center- New Orleans — New Orleans, Louisiana, United States
- Cancer Partners of Nebraska — Lincoln, Nebraska, United States
- New Mexico Cancer Care Alliance — Albuquerque, New Mexico, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Stony Brook University Cancer Center — Stony Brook, New York, United States
- The Ohio State University Wexner Medical Center James Cancer Hospital — Columbus, Ohio, United States
- Stephenson Cancer Center — Oklahoma City, Oklahoma, United States
- Oregon Health and Science University — Portland, Oregon, United States
- PRiSMs Group — Laredo, Texas, United States
- Virginia Cancer Institute — Richmond, Virginia, United States
- Swedish Cancer Institute — Seattle, Washington, United States
- University of Wisconsin Clinical Science Center — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.